Company Profile
Updated: 29-SEP-09Edison Pharmaceuticals Inc.
Private Company, Headquarters Location
5941 Optical Ct., Ste. 228, San Jose, CA 95138-1400, United States
(408)960-2910, (408)413-5300 fax, http://www.edisonpharma.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Development of drugs to treat diseases that impair energy metabolism.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Walgreen Co. Announces the Retirement of Three Board Members in January.
Biotech Week; 12/9/2009; 1136 words; ...Health Initiatives Inc. (a pharmacy benefit...Walgreens Mail Service Inc., Walgreens Home Care Inc., Walgreens Specialty...Gas, Commonwealth Edison, Engineering...Other Retail, Pharmaceutical, Pharmaceuticals, Retail, Seniors...
Studies from S. Rohatagi et al have provided new data on pharmacokinetics.
Biotech Week; 12/2/2009; 636 words; ...Development, 399 Thornall St., Edison, NJ 08837, USA. The publisher...contacted at: Sage Publications Inc., 2455 Teller Rd., Thousand...91320, USA. Keywords: City:Edison, State:NJ, Country:United...Clinical Pharmacy, Drugs, Pharmaceuticals, Pharmacokinetics, Pharmacology...
The LABJ stock index: tracking Los Angeles-area companies.(INVESTMENTS & FINANCE)(Statistical table)(Brief article)
Los Angeles Business Journal; 11/30/2009; 7024 words; ...7.3% US Auto Parts Network Inc. PRTS 4.76 -6.7% BIOMEDICAL/PHARMACEUTICAL Abraxis Bioscience Inc. ABII 34.00 -1.5% Amgen...3% Cavitation Technologies Inc. CVAT 0.29 -13.4% Edison International EIX 34.34 2...
Publication No. WO/2009/143268 Published on Nov. 26, Assigned to Edison Pharmaceuticals for Mitochondrial Disease Treatment (American Inventors)
US Fed News Service, Including US State News; 11/30/2009; 413 words; ...United States of America, have developed a treatment of mitochondrial diseas. The patent has been assigned to Edison Pharmaceuticals Inc., San Jose, Calif. According to an abstract posted by the World Intellectual Property Organization: "Methods...
Publication No. WO/2009/143235 Published on Nov. 26, Assigned to Edison Pharmaceuticals for Mitochondrial Disease Treatment (American Inventors)
US Fed News Service, Including US State News; 11/30/2009; 413 words; ...United States of America, have developed a treatment of mitochondrial diseas. The patent has been assigned to Edison Pharmaceuticals Inc., San Jose, Calif. According to an abstract posted by the World Intellectual Property Organization: "Methods...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning